Research Chemicals 4-AcO-DMT: What Researchers Should Know

4-AcO-DMT (4-acetoxy-N,N-dimethyltryptamine), often called psilacetin, is a synthetic tryptamine that acts as a prodrug of psilocin, the same metabolite the body produces from psilocybin. It is distributed as a reference standard for laboratory research and is not FDA-approved for human use in the United States. Most material appears as an off-white crystalline powder or as a fumarate or hydrochloride salt.

Because the compound sits in the same legal gray zone as many other designer tryptamines, researchers need to understand its chemistry, its scheduling status, and the documentation that should accompany any sample.

What Is 4-AcO-DMT (Psilacetin)?

4-AcO-DMT is an acetylated derivative of psilocin. Esterases remove the acetyl group at the 4-position after administration, which is why the molecule is described as a prodrug rather than an active compound in its own right.

It was first described in the scientific literature in 1963 by Albert Hofmann's research group. The compound has never completed modern clinical trials, so human pharmacological data remain sparse.

• Molecular formula: C14H18N2O2
• Molar mass: 246.31 g/mol
• Class: Substituted tryptamine (indolealkylamine)
• Common synonyms: Psilacetin, O-acetylpsilocin, 4-acetoxy-DMT

In the laboratory, 4-AcO-DMT is handled as a solid reference material and is typically characterized by NMR, HPLC, or mass spectrometry before use.

How 4-AcO-DMT Compares With Related Tryptamines

4-AcO-DMT is frequently discussed alongside other indolealkylamines. Some researchers compare it with research chemicals 5-meo-dmt, although the two differ sharply in potency and receptor profile.

Two conclusions matter here. Psilocybin, psilocin, and 5-MeO-DMT are all explicitly Schedule I in the United States. 4-AcO-DMT itself is not named in the federal schedules, which is exactly why it circulates as a research chemical rather than a pharmaceutical product.

Legal Status in the United States and Abroad

Federal scheduling does not list 4-AcO-DMT by name, but that does not make it legal to sell for human consumption. Prosecutors can invoke the Federal Analogue Act when a substance is substantially similar to a Schedule I or II drug and is intended for human use.

State law adds another layer. Several states have passed blanket bans on entire classes of Research Chemicals, and some specifically name 4-AcO-DMT or psilacetin. Anyone moving material across state lines should verify both federal and state rules first.

Suppliers in the research chemicals usa market often label the powder "not for human consumption," a disclaimer that reflects intended use but does not override analogue statutes or state bans.

Outside the United States, the picture is equally uneven. In the research chemicals europe market, countries such as the United Kingdom and Germany regulate the compound through generic psychoactive substance laws, while a handful of jurisdictions list it by name.

• US federal: unscheduled by name, Analogue Act exposure
• UK: covered by the Psychoactive Substances Act 2016
• Germany: regulated under the NpSG
• Japan: designated as a regulated substance

Safety, Handling, and Storage in the Lab

There is no established human safety profile for 4-AcO-DMT. No modern clinical trials have been published, and dosing, toxicity, and drug-interaction data are essentially absent.

Because of that gap, the compound should be treated as a hazardous material. Standard precautions include:

1. Work in a ventilated fume hood with gloves, eye protection, and a lab coat.
2. Weigh and handle material with dedicated tools to avoid cross-contamination.
3. Store the powder desiccated, protected from light, and at or below room temperature.
4. Maintain a written inventory and logbook, as many facilities require.
5. Dispose of waste through an approved chemical waste stream.

No published clinical data establish a safe human dose of 4-AcO-DMT, and the compound is not approved for human consumption in any country.

Stability and purity also vary with salt form and storage conditions. Anyone weighing personal use should speak with a licensed healthcare professional rather than rely on forum reports.

Sourcing, Purity, and Documentation

Reference standards should arrive with analytical documentation: an HPLC or GC trace, a mass spectrum, and an NMR spectrum where applicable. Price is a poor proxy for purity, so what matters is whether the supplier can explain the synthesis route, residual solvents, and the stability data behind the lot you receive.

Note also that chemicals for research are frequently shipped under strict packaging and documentation requirements. Customs seizures are common when tryptamine samples are mislabeled or declared inaccurately.

When comparing catalogs, verify the following before ordering:

• Third-party analytical testing, not in-house testing alone
• Batch-specific certificates of analysis
• Clear hazard labeling and safety data sheets
• Compliance with the destination country's import rules

4-AcO-DMT remains a poorly characterized tryptamine with no approved medical use. Its research value comes from its role as a psilocin prodrug, and that same prodrug behavior is what makes its legal and safety status worth verifying before any laboratory work begins.